Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EG7I
|
||||
Former ID |
DNC013115
|
||||
Drug Name |
H-Dmt-Tic-Lys(Ac)-NH-Ph
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528411] | ||
Structure |
Download2D MOL |
||||
Formula |
C35H43N5O5
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=<br />O)C)C(=O)NC4=CC=CC=C4)N)C)O
|
||||
InChI |
1S/C35H43N5O5/c1-22-17-28(42)18-23(2)29(22)20-30(36)35(45)40-21-26-12-8-7-11-25(26)19-32(40)34(44)39-31(15-9-10-16-37-24(3)41)33(43)38-27-13-5-4-6-14-27/h4-8,11-14,17-18,30-32,42H,9-10,15-16,19-21,36H2,1-3H3,(H,37,41)(H,38,43)(H,39,44)
|
||||
InChIKey |
VCTWEJIUVCJXEY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528411] | |
Mu-type opioid receptor | Target Info | Inhibitor | [528411] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.